Acquired prothrombin deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:26348D68.4
Who is this for?
Show terms as
1FDA treatments4Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Acquired prothrombin deficiency is a rare bleeding disorder where the body does not have enough of a clotting protein called prothrombin (also known as Factor II). Unlike inherited forms of prothrombin deficiency, this condition is not something you are born with — it develops during your lifetime due to another underlying cause. Prothrombin is made in the liver and plays a key role in helping blood clot properly. When levels are too low, the blood cannot clot as it should, leading to abnormal or excessive bleeding. This condition can be caused by several things, including liver disease (which reduces the liver's ability to make clotting proteins), vitamin K deficiency (since prothrombin depends on vitamin K to work), use of blood-thinning medications like warfarin, or rarely, the development of antibodies that attack prothrombin — a situation sometimes seen in people with lupus or other autoimmune conditions. Symptoms can range from easy bruising and prolonged bleeding from cuts to more serious internal bleeding. Treatment focuses on addressing the root cause, replacing clotting factors when needed, and stopping dangerous bleeding episodes. With proper management, many people do well, though outcomes depend heavily on what is causing the deficiency.

Also known as:

Key symptoms:

Easy or unexplained bruisingProlonged bleeding from cuts or woundsHeavy or unusually long menstrual periodsBleeding gumsNosebleeds that are hard to stopBlood in the urineBlood in the stoolBleeding into joints causing pain and swellingExcessive bleeding after surgery or dental proceduresSpontaneous internal bleeding in severe cases

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

1 available

PHYTONADIONE PHYTONADIONE

PHYTONADIONE· Dr.Reddy's Laboratories Inc■ Boxed Warning

anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives

No actively recruiting trials found for Acquired prothrombin deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Acquired prothrombin deficiency community →

Specialists

4 foundView all specialists →
MM
Michael Stevenson, MD
Specialist
PI on 1 active trial
IP
Ingrid Pabinger-Fasching, Prof.
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Acquired prothrombin deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acquired prothrombin deficiencyForum →

No community posts yet. Be the first to share your experience with Acquired prothrombin deficiency.

Start the conversation →

Latest news about Acquired prothrombin deficiency

No recent news articles for Acquired prothrombin deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is causing my prothrombin deficiency, and can that underlying cause be treated?,What are my current prothrombin levels, and what level is considered safe?,What should I do if I have a bleeding episode at home — when should I go to the emergency room?,Are there any medications, supplements, or foods I should avoid that could make bleeding worse?,Do I need to take any precautions before dental work or surgery?,How often do I need blood tests to monitor my condition?,Is there a risk that this condition could come back after treatment?

Common questions about Acquired prothrombin deficiency

What is Acquired prothrombin deficiency?

Acquired prothrombin deficiency is a rare bleeding disorder where the body does not have enough of a clotting protein called prothrombin (also known as Factor II). Unlike inherited forms of prothrombin deficiency, this condition is not something you are born with — it develops during your lifetime due to another underlying cause. Prothrombin is made in the liver and plays a key role in helping blood clot properly. When levels are too low, the blood cannot clot as it should, leading to abnormal or excessive bleeding. This condition can be caused by several things, including liver disease (whic

How is Acquired prothrombin deficiency inherited?

Acquired prothrombin deficiency follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Acquired prothrombin deficiency?

4 specialists and care centers treating Acquired prothrombin deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.